BIOMAT Database Logo BIOMAT Database Logo

[Nifedipine in the treatment of pulmonary hypertension. I--Primary pulmonary hypertension]. 1986

S M Barreto, and F M de Freitas

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014655 Vascular Resistance The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT. Peripheral Resistance,Total Peripheral Resistance,Pulmonary Vascular Resistance,Systemic Vascular Resistance,Peripheral Resistance, Total,Resistance, Peripheral,Resistance, Pulmonary Vascular,Resistance, Systemic Vascular,Resistance, Total Peripheral,Resistance, Vascular,Vascular Resistance, Pulmonary,Vascular Resistance, Systemic
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

S M Barreto, and F M de Freitas
Nifedipine in the treatment of primary pulmonary hypertension.
April 1983, American heart journal,
S M Barreto, and F M de Freitas
Failure of nifedipine treatment in primary pulmonary hypertension.
May 1982, British heart journal,
S M Barreto, and F M de Freitas
Nifedipine in primary pulmonary hypertension.
June 1984, Journal of the American College of Cardiology,
S M Barreto, and F M de Freitas
Nifedipine and primary pulmonary hypertension.
March 1984, Annals of internal medicine,
S M Barreto, and F M de Freitas
Primary pulmonary hypertension: effects of nifedipine.
September 1980, British heart journal,
S M Barreto, and F M de Freitas
Primary pulmonary hypertension: effects of nifedipine.
August 1981, British heart journal,
S M Barreto, and F M de Freitas
Pulmonary edema with nifedipine in primary pulmonary hypertension.
January 1985, Respiration; international review of thoracic diseases,
S M Barreto, and F M de Freitas
Primary pulmonary hypertension, nifedipine, and hypoxemia.
January 1984, Annals of internal medicine,
S M Barreto, and F M de Freitas
[Use of nifedipine in primary arterial pulmonary hypertension].
July 1982, Arquivos brasileiros de cardiologia,
S M Barreto, and F M de Freitas
Hemodynamic effects of nifedipine in primary pulmonary hypertension.
July 1983, Journal of the American College of Cardiology,
Copied contents to your clipboard!